Good morning, Hubsters. Senior reporter Michael Schoeck here with the US edition of the Wire from the New York newsroom, filling in for Obey Martin Manayiti for a while.
PEI Group’s NEXUS 2025 summit is in full swing in sunny Orlando. This morning we have a day-one video interview clip with Riverside Company’s co-CEO Stewart Kohl, who spoke with PE Hub editor-in-chief MK Flynn about the deal market environment.
Next up we have a healthcare information technology update from John R Fischer.
And we’ll close out today with a deal announcement involving a healthcare technology add-on.
Bright sunshine forecast
“I understand right now there’s a dip, a bump in the road if you will, caused by a lot of volatility and even a feeling of perhaps chaos,” said Stewart Kohl, co-CEO at Riverside, referring to the current slowdown in dealmaking.
The conversation took place at PEI Group’s NEXUS 2025 summit on Monday.
To hear more about when Kohl expects deal activity to pick up, sign up for the premium version of the Wire.
And if you’re at NEXUS, feel free to shoot PE Hub editor-in-chief MK Flynn ([email protected]) and reporter Rafael Canton ([email protected]) a message if you’re interested in meeting up.
Tech-enabled healthcare
Healthcare IT remains one of the most active subsectors for dealmaking in the healthcare industry.
Learn more about how revenue cycle management systems are recalibrating the fragmented third-party vendor healthcare market by signing up for the premium version of the Wire.
Clinical assessments
Keeping with healthcare technology for a moment, Clario, a portfolio company of Astorg, Nordic Capital, Cinven and Novo Holdings, announced a late Monday agreement to acquire WCG’s electronic clinical outcome assessments business for undisclosed terms.
That’s a wrap for me. Keep an eye out for the Europe edition of the Wire tomorrow from Craig McGlashan and the US edition from Rafael Canton.
Cheers,
Michael
Read the full Wire commentary on PE Hub ...